Goldman Sachs Maintains Sell Rating on Marsh & McLennan
Goldman Sachs has reiterated its Sell rating on Marsh & McLennan Companies, Inc. (NYSE: MMC), maintaining a price target of $220.00. Despite the firm updating its earnings per share (EPS) estimates for the years 2025-2026 with a slight increase of around 0.5%, it noted that these expectations are still about 3% below the consensus forecast from Visible Alpha.
This latest revision from Goldman Sachs reflects an improvement of roughly 30 basis points in adjusted operating margins. However, this positive adjustment is somewhat counterbalanced by lower predictions for organic growth and an increase of 50 basis points in the effective tax rate, now estimated at 26.5%.
Even with Marsh & McLennan set to potentially meet its fiscal year 2024 guidance, which includes mid-single-digit growth and margin expansion, Goldman Sachs is cautious. They stress that consensus estimates may be overly optimistic, particularly when considering the pressures faced in organic growth and the margins that are expected.
Goldman Sachs projects a modest slowdown in organic growth into the first half of 2025, citing anticipated near-term pressure in discretionary consulting services from both Oliver Wyman and Career.
The investment firm's core margin expansion expectations for Marsh & McLennan's Risk and Insurance Services (RIS) have been adjusted upwards to 50 basis points for 2026, from a lower estimate of 30 basis points previously. Nonetheless, their overall margin estimates are still below the consensus by 60 basis points, largely due to the expected effects on fiduciary investment outcomes and fading advantages from the company’s restructuring efforts.
Additionally, the guidance for Marsh & McLennan's adjusted effective tax rate for 2024 was revised upward to 26.5%, up from the earlier forecast of 25.5% to 26.5% at the start of the year.
Recent Performance and Acquisitions
In a notable development, Marsh McLennan reported encouraging performance in the third quarter of 2024, achieving a 5% increase in underlying revenue along with a significant 12% rise in adjusted operating income. The company reported an adjusted EPS of $1.63, marking a 4% increase year-over-year, with consolidated revenues reaching an impressive $5.7 billion.
The firm recently made headlines with its acquisition of McGriff Insurance Services for $7.75 billion, an action expected to be modestly accretive to their adjusted EPS in the initial year following the deal's closure.
Looking ahead, Marsh McLennan’s outlook for 2024 remains optimistic, with anticipated mid-single-digit revenue growth and ongoing margin expansion. A projected capital deployment of around $4.2 billion sets the stage for future growth, despite potential challenges that may arise from increased transaction risks as they progress into 2025, particularly due to geopolitical and cyber threats.
Key Insights from InvestingPro Data
Marsh & McLennan Companies, Inc. (NYSE: MMC) offers a complex picture for investors, as revealed by the latest data from InvestingPro. The company boasts a notable market capitalization of approximately $111.59 billion, which highlights its influential role in the insurance sector.
One noteworthy aspect from InvestingPro is MMC's remarkable achievement of raising its dividend for 15 consecutive years, showcasing a strong commitment to providing returns to shareholders. This durability in dividends becomes particularly relevant in the context of Goldman Sachs' more cautious outlook, as it suggests the company's financial resilience amidst potential adversities. Notably, MMC has sustained its dividend payments for a commendable 54 years consistently, emphasizing its reliability as an income-generating stock.
Further insights into the company’s financial stability are evidenced by its revenue of $23.95 billion over the past twelve months coupled with a gross profit margin of 44.77%, indicating strong operational efficiency. The operating income margin of 26.66% further reinforces this perspective.
Nevertheless, potential investors should keep in mind that MMC is currently trading at a relatively high P/E ratio of 28.11, aligning with Goldman Sachs' concerns regarding overly optimistic market expectations. This valuation, alongside the InvestingPro tip highlighting that MMC is trading near its 52-week high, suggests that the stock could be fully valued at its present levels.
Frequently Asked Questions
What is Goldman Sachs' current rating on Marsh & McLennan?
Goldman Sachs has maintained a Sell rating on Marsh & McLennan, with a price target of $220.00.
How does Marsh & McLennan's recent performance compare to past results?
In Q3 2024, Marsh & McLennan experienced a 5% rise in underlying revenue and a 12% increase in adjusted operating income, signaling strong performance.
What significant acquisition did Marsh & McLennan complete recently?
Marsh & McLennan acquired McGriff Insurance Services for $7.75 billion, expected to enhance its adjusted EPS in the first year.
What is Marsh & McLennan's outlook for 2024?
The company anticipates mid-single-digit revenue growth and continued margin expansion, with planned capital deployment of approximately $4.2 billion.
How has Marsh & McLennan performed in terms of dividends?
MMC has successfully raised its dividend for 15 consecutive years, demonstrating a strong commitment to shareholder returns.
